LIFNano Therapeutics Investors
LIFNano Therapeutics specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor.
Founded Date:
2015
Number Of Exists:
Grant
Industry:
Advanced and Next Generation Therapies (Various)
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Technology:
Advanced Longevity (R&D)
Investor Type:
Healthcare Company
Employee Number:
1-10